539 related articles for article (PubMed ID: 26627449)
41. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study.
Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E
BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.
Laskin BL; Goebel J; Starke JR; Schauer DP; Eckman MH
Am J Kidney Dis; 2013 Jan; 61(1):22-32. PubMed ID: 22784996
[TBL] [Abstract][Full Text] [Related]
43. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
44. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore.
Lim VW; Wee HL; Lee P; Lin Y; Tan YR; Tan MX; Lin LW; Yap P; Chee CB; Barkham T; Lee V; Chen M; Ong RT
BMJ Open; 2021 Jul; 11(7):e050629. PubMed ID: 34266845
[TBL] [Abstract][Full Text] [Related]
45. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
Campbell JR; Sasitharan T; Marra F
Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
[TBL] [Abstract][Full Text] [Related]
46. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries.
Alvarez GG; Clark M; Altpeter E; Douglas P; Jones J; Paty MC; Posey DL; Chemtob D
Int J Tuberc Lung Dis; 2010 Dec; 14(12):1530-7. PubMed ID: 21144237
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
[TBL] [Abstract][Full Text] [Related]
48. Impact of Routine Quantiferon Testing on Latent Tuberculosis Diagnosis and Treatment in Refugees in Multnomah County, Oregon, November 2009-October 2012.
Walters JK; Sullivan AD
J Immigr Minor Health; 2016 Apr; 18(2):292-300. PubMed ID: 25784140
[TBL] [Abstract][Full Text] [Related]
49. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
[TBL] [Abstract][Full Text] [Related]
50. Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study.
Liu Y; Posey DL; Cetron MS; Painter JA
Ann Intern Med; 2015 Mar; 162(6):420-8. PubMed ID: 25775314
[TBL] [Abstract][Full Text] [Related]
51. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
[TBL] [Abstract][Full Text] [Related]
52. Overseas screening for tuberculosis in U.S.-bound immigrants and refugees.
Liu Y; Weinberg MS; Ortega LS; Painter JA; Maloney SA
N Engl J Med; 2009 Jun; 360(23):2406-15. PubMed ID: 19494216
[TBL] [Abstract][Full Text] [Related]
53. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
Verma G; Chuck AW; Jacobs P
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
[TBL] [Abstract][Full Text] [Related]
54. Screening and Treatment Rates for Latent Tuberculosis Among Newly-Arrived Refugees in an Urban Facility in Connecticut.
Duchen D; Boyd AT; Annamalai A
Conn Med; 2017 May; 81(5):291-298. PubMed ID: 29738131
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
[TBL] [Abstract][Full Text] [Related]
56. A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
Kawatsu L; Uchimura K; Ohkado A
Int J Tuberc Lung Dis; 2020 May; 24(5):506-511. PubMed ID: 32398200
[No Abstract] [Full Text] [Related]
57. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S
PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502
[TBL] [Abstract][Full Text] [Related]
58. Overseas screening for tuberculosis in immigrants and refugees to the United States: current status.
Binkin NJ; Zuber PL; Wells CD; Tipple MA; Castro KG
Clin Infect Dis; 1996 Dec; 23(6):1226-32. PubMed ID: 8953062
[TBL] [Abstract][Full Text] [Related]
59. Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.
Thee S; Krüger R; von Bernuth H; Meisel C; Kölsch U; Kirchberger V; Feiterna-Sperling C
PLoS One; 2019; 14(5):e0216234. PubMed ID: 31112542
[TBL] [Abstract][Full Text] [Related]
60. Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.
Mullie GA; Schwartzman K; Zwerling A; N'Diaye DS
BMC Med; 2017 May; 15(1):104. PubMed ID: 28514962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
